TTRX

Conviction 57HealthcareScan · Thu, Jun 25, 2026

TTRX$6.79+11.49%

ResistanceSupportVol 14

Vol MA14 37.25K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Turn Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.turntherapeutics.com ↗

Price6.79

Change+11.49%

Gap-2.46%

Rel volume0.30×

Avg volume58.49K

Avg $ vol345.97K

SMA 205.86

SMA 504.73

SMA 200—

Price vs 50+43.48%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 4.70

RSI (14)69

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D92 / 76

ADX (14)32

+DI / −DI31 / 14

RSI divergence—

MACD divergence—

ATR %+8.27%

ADR %10.63%

52w high9.20

52w low2.71

From 52w high-26.20%

Above 52w low+150.55%

New 52w highNo

SqueezeOff

Bollinger width30.88%

%B1.01

Donchian pos92.89%

Donchian high6.96

Donchian low4.57

AVWAP (52w high)10.74

vs AVWAP high-36.80%

AVWAP (52w low)4.18

vs AVWAP low+62.31%

OBV trendFlat

Chaikin MF (20)0.19

Today vs 20d0.30×

Avg vol (14d)37.25K

Avg vol (20d)58.49K

Avg $ vol (20d)345.97K

Market cap202.26M

RS 3m (vs SPY)+70.08%

RS 6m (vs SPY)+95.26%

RS line new highNo

Trend template—

Technical rank96.3

1 week+12.60%

1 month+26.68%

3 months+99.12%

6 months+124.83%

1 year—

YTD+44.78%

P/E-63.32

P/B33.06

P/S—

P/FCF—

EPS-0.1200

Div yield—

ROE-52.21%

ROA-17.13%

Debt/Eq0.97

Current2.23

EV/EBITDA-33.96

Gross margin—

Net margin—

Rev growth—

EPS growth-80.62%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value197.19M

Revenue—

Net income-970.97K

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out29.79M

Employees2

ListedWed, Oct 8, 2025

Free float8.02M

Float %27.2%

Short interest63.73K

Days to cover1.0d

Short volume40.7%

Squeeze score7 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank96.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.68

Support4.12

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TTRX

All disclosures →

No recent disclosed trades by Congress in TTRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TTRX · 6 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Dewhurst Martin William Director · Stock option (right to buy) · 2026-06-04	Grant	71.67K	$0	2026-06-04	2026-06-08
GOLDEN ARTHUR F Director · Stock option (right to buy) · 2026-06-04	Grant	89.58K	$0	2026-06-04	2026-06-08
Kester Kent Edward Director · Stock option (right to buy) · 2026-06-04	Grant	83.33K	$0	2026-06-04	2026-06-08
Gengos Andrew Director · Stock option (right to buy) · 2026-06-04	Grant	95K	$0	2026-06-04	2026-06-08
BEB Holdings, LLC 10% owner · Common Stock · 2026-05-28	Gift	300K	$0	2026-05-28	2026-06-01
BEB Holdings, LLC 10% owner · Common Stock · 2026-05-28	Gift	300K	$0	2026-05-28	2026-06-01
Burnam Bradley Evan Chief Executive Officer · Common Stock · 2026-05-28	Gift	300K	$0	2026-05-28	2026-06-01
Burnam Bradley Evan Chief Executive Officer · Common Stock · 2026-05-28	Gift	300K	$0	2026-05-28	2026-06-01

SEC filings

EDGAR filings in TTRX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.